Sara Maldonado-Martín1, Peter H Brubaker2, Joel Eggebeen3, Kathryn P Stewart3, Dalane W Kitzman2. 1. Department of Physical Education and Sport, Faculty of Education and Sport-Physical Activity and Sport Section, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Araba/Álava, Basque Country, Spain. Electronic address: sara.maldonado@ehu.eus. 2. Department of Health and Exercise Science, Wake Forest School of Medicine, Winston-Salem, NC. 3. Sections on Cardiovascular Medicine and Geriatrics, Department of Internal Medicine, Wake Forest University, Winston-Salem, NC.
Abstract
OBJECTIVE: To evaluate the change in the 6-minute walk test (6-MWT) distance relative to changes in key functional capacity measures after 16 weeks of exercise training in older patients (≥65y) who have heart failure with preserved ejection fraction (HFpEF). DESIGN: Prospective, randomized, single-blinded (by researchers to patient group) comparison of 2 groups of HFpEF patients. SETTING: Hospital and clinic records; ambulatory outpatients. PARTICIPANTS: Participants (N=47) randomly assigned to anattention control (AC) (n=24) or exercise training (ET) (n=23) group. INTERVENTION: The ET group performed cycling and walking at 50% to 70% of peak oxygen uptake (V˙o2peak) intensity (3d/wk, 60min each session). MAIN OUTCOME MEASURES: V˙o2peak, ventilatory threshold (VT), and 6-MWT distance were measured at baseline and after the 16-week study period. RESULTS: At follow-up, the 6-MWT distance was higher than at the baseline in both the ET (11%, P=.005) and AC (9%, P=.004) groups. In contrast, V˙o2peakand VT values increased in the ET group (19% and 11%, respectively; P=.001), but decreased in the AC group at follow-up (2% and 0%, respectively). The change in V˙o2peak versus 6-MWT distance after training was also not significantly correlated in the AC group (r=.01, P=.95) or in the ET group (r=.13, P=.57). The change in 6-MWT distance and VT (an objective submaximal exercise measure) was also not significantly correlated in the AC group (r=.08, P=.74) or in the ET group (r=.16, P=.50). CONCLUSIONS: The results of this study challenge the validity of using the 6-MWT as a serial measure of exercise tolerance in elderly HFpEF patients and suggest that submaximal and peak exercise should be determined objectively by VT and V˙o2peak in this patient population.
RCT Entities:
OBJECTIVE: To evaluate the change in the 6-minute walk test (6-MWT) distance relative to changes in key functional capacity measures after 16 weeks of exercise training in older patients (≥65y) who have heart failure with preserved ejection fraction (HFpEF). DESIGN: Prospective, randomized, single-blinded (by researchers to patient group) comparison of 2 groups of HFpEF patients. SETTING: Hospital and clinic records; ambulatory outpatients. PARTICIPANTS: Participants (N=47) randomly assigned to an attention control (AC) (n=24) or exercise training (ET) (n=23) group. INTERVENTION: The ET group performed cycling and walking at 50% to 70% of peak oxygen uptake (V˙o2peak) intensity (3d/wk, 60min each session). MAIN OUTCOME MEASURES: V˙o2peak, ventilatory threshold (VT), and 6-MWT distance were measured at baseline and after the 16-week study period. RESULTS: At follow-up, the 6-MWT distance was higher than at the baseline in both the ET (11%, P=.005) and AC (9%, P=.004) groups. In contrast, V˙o2peak and VT values increased in the ET group (19% and 11%, respectively; P=.001), but decreased in the AC group at follow-up (2% and 0%, respectively). The change in V˙o2peak versus 6-MWT distance after training was also not significantly correlated in the AC group (r=.01, P=.95) or in the ET group (r=.13, P=.57). The change in 6-MWT distance and VT (an objective submaximal exercise measure) was also not significantly correlated in the AC group (r=.08, P=.74) or in the ET group (r=.16, P=.50). CONCLUSIONS: The results of this study challenge the validity of using the 6-MWT as a serial measure of exercise tolerance in elderly HFpEF patients and suggest that submaximal and peak exercise should be determined objectively by VT and V˙o2peak in this patient population.
Authors: Sara Maldonado-Martín; Peter H Brubaker; Leonard A Kaminsky; J Brian Moore; Kathryn P Stewart; Dalane W Kitzman Journal: Med Sci Sports Exerc Date: 2006-06 Impact factor: 5.411
Authors: Mark J Haykowsky; Peter H Brubaker; Jerry M John; Kathryn P Stewart; Timothy M Morgan; Dalane W Kitzman Journal: J Am Coll Cardiol Date: 2011-07-12 Impact factor: 24.094
Authors: Dalane W Kitzman; Peter H Brubaker; Timothy M Morgan; Kathryn P Stewart; William C Little Journal: Circ Heart Fail Date: 2010-09-17 Impact factor: 8.790
Authors: Dalane W Kitzman; Peter H Brubaker; David M Herrington; Timothy M Morgan; Kathryn P Stewart; W Gregory Hundley; Abdelhamed Abdelhamed; Mark J Haykowsky Journal: J Am Coll Cardiol Date: 2013-05-09 Impact factor: 24.094
Authors: Daniel E Forman; Jerome L Fleg; Dalane W Kitzman; Clinton A Brawner; Ann M Swank; Robert S McKelvie; Robert M Clare; Stephen J Ellis; Mark E Dunlap; Vera Bittner Journal: J Am Coll Cardiol Date: 2012-11-21 Impact factor: 24.094
Authors: Windy W Alonso; Kevin A Kupzyk; Joseph F Norman; Scott W Lundgren; Alfred Fisher; Merry L Lindsey; Steven J Keteyian; Bunny J Pozehl Journal: J Card Fail Date: 2021-09-15 Impact factor: 5.712
Authors: Matthew Nayor; Nicholas E Houstis; Mayooran Namasivayam; Jennifer Rouvina; Charles Hardin; Ravi V Shah; Jennifer E Ho; Rajeev Malhotra; Gregory D Lewis Journal: JACC Heart Fail Date: 2020-06-10 Impact factor: 12.035
Authors: Charlotte Schubert; Gareth Archer; Jo M Zelis; Sarah Nordmeyer; Kilian Runte; Anja Hennemuth; Felix Berger; Volkmar Falk; Pim A L Tonino; Rod Hose; Herman Ter Horst; Titus Kuehne; Marcus Kelm Journal: NPJ Digit Med Date: 2020-07-09
Authors: Gohar Azhar; Jeanne Y Wei; Scott E Schutzler; Karen Coker; Regina V Gibson; Mitchell F Kirby; Arny A Ferrando; Robert R Wolfe Journal: J Gerontol A Biol Sci Med Sci Date: 2021-06-14 Impact factor: 6.053